HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
Cash from Operating Activities
HLS Therapeutics Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
Cash from Operating Activities
$15.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
Cash from Operating Activities
-CA$298k
|
CAGR 3-Years
23%
|
CAGR 5-Years
29%
|
CAGR 10-Years
-16%
|
See Also
What is HLS Therapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
15.8m
USD
Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's Cash from Operating Activities amounts to 15.8m USD.
What is HLS Therapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-2%
Over the last year, the Cash from Operating Activities growth was -7%. The average annual Cash from Operating Activities growth rates for HLS Therapeutics Inc have been 19% over the past three years , -14% over the past five years , and -2% over the past ten years .